https://www.openbell.ai/ 2026-10-14T11:50:55.308Z hourly 1.0 https://www.openbell.ai/support 2026-10-14T11:50:55.308Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-14T11:50:55.308Z monthly 0.5 https://www.openbell.ai/terms 2026-10-14T11:50:55.308Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-14T11:50:55.308Z hourly 0.8 https://www.openbell.ai/news/MANH:1791978646675 2026-10-14T11:50:46.675Z daily 0.9 https://cdn.brandfetch.io/MANH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stifel Maintains Buy on Manhattan Associates, Raises Price Target to $250 Stifel analyst Parker Lane has maintained a Buy rating on Manhattan Associates (NASDAQ: MANH) and increased the price target from $225 to $250. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/KNDI:1791978557019 2026-10-14T11:49:17.019Z daily 0.9 https://cdn.brandfetch.io/KNDI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kandi Technologies shares are trading lower after the company announced a 1-for-10 reverse stock split, effective October 16. openbell Financial News https://www.openbell.ai/news/SOTK:1791978405868 2026-10-14T11:46:45.868Z daily 0.9 https://cdn.brandfetch.io/SOTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sono-Tek shares are trading lower after the company reported worse-than-expected Q2 financial results. openbell Financial News https://www.openbell.ai/news/BTCUSD:1791978309270 2026-10-14T11:45:09.270Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/MG-7884.jpg?width=250&height=187 Peter Schiff Says World Heading Toward Debt Crisis, Warns US Situation 'Particularly' Problematic: 'Currencies Are Going to Be Debased' Economist Peter Schiff warns of an impending global debt crisis, particularly affecting the U.S., where national debt has exceeded $40.29 trillion and the fiscal year 2026 budget deficit has reached $1.97 trillion. He predicts that the federal government may default on its obligations, leading to higher yields on long-dated Treasuries, potentially reaching 8%. Schiff also anticipates that central banks will be pressured to print money, resulting in the debasement of currencies, including the U.S. dollar. https://www.openbell.ai/news/FFAI:1791978300965 2026-10-14T11:45:00.965Z daily 0.9 https://cdn.brandfetch.io/FFAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 7:45:00 AM ET: Quotation Resumption: News and Resumption Times openbell Financial News https://www.openbell.ai/news/BAC:1791978270391 2026-10-14T11:44:30.391Z daily 0.9 https://cdn.brandfetch.io/BAC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bank Of America CFO Says We Enter The Final Quarter Of 2026 With Good Momentum Bank of America CFO indicated that the company is entering the final quarter of 2026 with positive momentum. Specific financial figures or detailed strategic changes were not provided in the media call. The statement suggests a favorable outlook for the bank's performance in the upcoming quarter. https://www.openbell.ai/news/IQV:1791978263322 2026-10-14T11:44:23.322Z daily 0.9 https://cdn.brandfetch.io/IQV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $303 Stifel analyst Shlomo Rosenbaum has maintained a Buy rating on IQVIA Holdings (NYSE: IQV) and increased the price target from $276 to $303. https://www.openbell.ai/news/YRD:1791978241672 2026-10-14T11:44:01.672Z daily 0.9 https://cdn.brandfetch.io/YRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Yiren Digital shares are trading higher as the company reaffirmed its $20 million share buyback program and highlighted a strong cash position of $250 million. openbell Financial News https://www.openbell.ai/news/ACN:1791978214760 2026-10-14T11:43:34.760Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Accenture Targets Operating Margin Expansion Of 10-30bps Over FY27-29; Projects Mid-Single Digit Revenue Growth In FY27 And FY28, With Mid To High Single Digit Growth In FY29; Targets $5.5B Of Share Repurchases In FY27 Accenture has set a target for operating margin expansion of 10-30 basis points over fiscal years 2027 to 2029. The company projects mid-single digit revenue growth for fiscal years 2027 and 2028, with expectations of mid to high single digit growth in fiscal year 2029. Additionally, Accenture aims to execute $5.5 billion in share repurchases in fiscal year 2027. https://www.openbell.ai/news/NUR:1791978104679 2026-10-14T11:41:44.679Z daily 0.9 https://cdn.brandfetch.io/NUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud NuRAN Wireless Activates 29 Towers In October; Sites Advance Conversion Of Its Contracted Backlog Of 5K+ Towers Into Operating Assets And Recurring Revenue NuRAN Wireless activated 29 towers in October, advancing its backlog of over 5,000 contracted towers with expected revenues exceeding $900 million over five to ten years. The company is developing NuEnergy, a platform for solar, battery-storage, and hybrid power systems to enhance site economics and create recurring revenue opportunities. NuRAN aims to address the significant connectivity gap in rural Sub-Saharan Africa, where 40% of the population lacks mobile internet access, by providing reliable power solutions and exploring additional energy services. The African telecom-tower market is projected to grow from $4.46 billion in 2025 to $7.82 billion by 2035, with renewable-powered sites expected to grow at an annual rate of 11.7% through 2031. https://www.openbell.ai/news/TGL:1791978051437 2026-10-14T11:40:51.437Z daily 0.9 https://cdn.brandfetch.io/TGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Treasure Global shares are trading higher after the company reported a narrower Q4 loss driven by strong revenue growth. openbell Financial News https://www.openbell.ai/news/WFC:1791977950717 2026-10-14T11:39:10.717Z daily 0.9 https://cdn.brandfetch.io/WFC/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Nine Big Banks Engaged in Debanking Practices, US Regulator Says' - Bloomberg A US regulator has reported that nine major banks, including Wells Fargo (WFC), are involved in debanking practices, which refers to the process of cutting off banking services to certain customers or sectors. The findings raise concerns about the implications for financial inclusion and the overall banking industry. Specific details regarding the financial impact or stock price movements were not disclosed in the article. https://www.openbell.ai/news/ARWR:1791977831738 2026-10-14T11:37:11.738Z daily 0.9 https://cdn.brandfetch.io/ARWR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arrowhead Reports First Clinical Validation Of TRiM Platform As ARO-MAPT Achieves Up To 73% Mean and 85% Maximum Tau Reduction Arrowhead Pharmaceuticals (NASDAQ: ARWR) announced interim results from its Phase 1/2a study of ARO-MAPT, achieving a mean cerebrospinal fluid total tau reduction of 73% and a maximum reduction of 85% after subcutaneous administration. This marks the first clinical validation of Arrowhead's TRiM™ platform for delivering siRNA across the blood-brain barrier. The results support the potential for quarterly dosing of the investigational RNA interference therapeutic aimed at treating Alzheimer's disease and other tauopathies. https://www.openbell.ai/news/SPCX:1791977769862 2026-10-14T11:36:09.862Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Kuala-Lumpur--Malaysia---Mar-31--2025-Sp.jpg?width=250&height=187 Elon Musk’s SpaceX Caps Military Starlink Speeds in Ukraine, Adviser Suspects Political Motive: ‘Cannot Be a Coincidence’ SpaceX has imposed a speed limit of 100 mph (160 km/h) on its military-grade Starlink service in Ukraine, disrupting military operations according to a Ukrainian official. The cap affects mobile terminals and was implemented without prior warning to Ukraine's defense forces. This decision is suspected to be politically motivated, coinciding with recent tensions in U.S.-Ukraine relations, particularly following comments made by former President Donald Trump regarding Ukraine's leadership. Previously, a speed cap of 90 km/h was also established to target Russian drones. https://www.openbell.ai/news/USO:1791977739509 2026-10-14T11:35:39.509Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Russia Can Boost Diesel Exports To 3.5M T/Month By 2026 End Russia is projected to increase its diesel exports to 3.5 million tons per month by the end of 2026, according to a report by Reuters citing TASS. This potential growth in exports may have significant implications for global diesel supply and pricing. The stock ticker associated with this news is USO. https://www.openbell.ai/news/BABA:1791977726679 2026-10-14T11:35:26.679Z daily 0.9 https://cdn.brandfetch.io/BABA/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Alibaba's Qwen Deepens Personal Agent Push With New AI Glasses, Earbuds' - YiCai Global Alibaba's Qwen has announced the launch of new AI glasses and earbuds as part of its strategy to enhance personal agent technology. This move aligns with the company's focus on integrating AI into consumer products. The introduction of these devices is expected to strengthen Alibaba's position in the competitive tech market. https://www.openbell.ai/news/ARWR:1791977693406 2026-10-14T11:34:53.406Z daily 0.9 https://cdn.brandfetch.io/ARWR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arrowhead’s ARO-MAPT Validates Brain Delivery Platform, Driving Significant Tau Suppression Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced interim results from its Phase 1/2a study of ARO-MAPT, an investigational RNA interference therapeutic for Alzheimer's disease. The TRiM™ platform successfully delivered siRNA across the blood-brain barrier, achieving a mean cerebrospinal fluid total tau reduction of 73% on Day 105, with a maximum reduction of 85%. This clinical validation supports the potential for quarterly dosing of ARO-MAPT. https://www.openbell.ai/news/ARWR:1791977564294 2026-10-14T11:32:44.294Z daily 0.9 https://cdn.brandfetch.io/ARWR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arrowhead Announces Interim Results From Ongoing Phase 1/2a Study Of ARO-MAPT, Investigational RNAi Therapeutic Being Developed As Potential Treatment For Alzheimer’s Disease And Other Tauopathies Arrowhead Pharmaceuticals (NASDAQ: ARWR) announced interim results from its Phase 1/2a study of ARO-MAPT, an investigational RNAi therapeutic for Alzheimer's disease. The study demonstrated a mean cerebrospinal fluid total tau reduction of 73% on Day 105, with individual reductions reaching up to 85%, indicating the potential for quarterly dosing. This marks the first clinical validation of Arrowhead's TRiM™ platform for delivering siRNA across the blood-brain barrier. A webinar to discuss additional results is scheduled for October 14 at 2:30 PM ET. https://www.openbell.ai/news/BTLN:1791977462069 2026-10-14T11:31:02.069Z daily 0.9 https://cdn.brandfetch.io/BTLN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brightline Interactive Regains Nasdaq Compliance Brightline Interactive, Inc. (NASDAQ: BTLN) has regained compliance with Nasdaq listing rules as of October 12, 2026. The company received confirmation that its common stock has maintained a closing bid price of at least $1.00 per share for 10 consecutive business days, resolving previous compliance issues. https://www.openbell.ai/news/MS:1791977254945 2026-10-14T11:27:34.945Z daily 0.9 https://cdn.brandfetch.io/MS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Morgan Stanley Q3 EPS $3.03 Beats $2.92 Estimate, Sales $20.338B Beat $19.954B Estimate Morgan Stanley reported Q3 earnings per share of $3.03, surpassing the analyst estimate of $2.92 by 3.77%, and marking an 8.21% increase from $2.80 per share in the same quarter last year. The company's quarterly sales reached $20.338 billion, exceeding the expected $19.954 billion by 1.93%, and reflecting an 11.75% increase from $18.200 billion in the prior year. https://www.openbell.ai/news/FFAI:1791977100522 2026-10-14T11:25:00.522Z daily 0.9 https://cdn.brandfetch.io/FFAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halted at 7:25:00 a.m. ET - Trading Halt: Halt News Pending openbell Financial News https://www.openbell.ai/news/BABA:1791976977084 2026-10-14T11:22:57.084Z daily 0.9 https://cdn.brandfetch.io/BABA/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Alibaba's Qwen Deepens Personal Agent Push With New AI Glasses, Earbuds' - YiCai Global Alibaba's Qwen has launched new AI glasses and earbuds as part of its strategy to enhance personal agent capabilities. This move aligns with the company's focus on integrating advanced technology into consumer products. The introduction of these devices is expected to strengthen Alibaba's position in the competitive AI market. https://www.openbell.ai/news/ZTG:1791976976134 2026-10-14T11:22:56.134Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Mobile-Device-Displaying-A-Rising-Candle.jpg?width=250&height=187 ZTG Stock Soars 15% Pre-Market After AI Pivot: Here’s What You Need to Know Zenta Group Co Ltd (NASDAQ: ZTG) shares surged nearly 15% in pre-market trading following the company's strategic pivot towards artificial intelligence and data solutions, announced by its board on Tuesday. This shift is supported by a recent agreement to acquire 100% of ZentoAI Intelligent Technology Company Limited, which develops AI and big data platforms. The company aims to focus resources on long-term growth in AI, moving away from property markets due to uncertain outlooks in the Guangdong–Hong Kong–Macao Greater Bay Area. https://www.openbell.ai/news/USO:1791976921232 2026-10-14T11:22:01.232Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Iran shifting tactics to step up attacks on shipping before US vote, officials say' - Reuters Iran is reportedly changing its tactics to increase attacks on shipping in the Gulf region ahead of the upcoming U.S. elections, according to officials. This shift in strategy could have significant implications for global oil markets and shipping routes. The situation may affect the stock performance of companies linked to oil, such as USO, as tensions in the region escalate. https://www.openbell.ai/news/QCOM:1791976856093 2026-10-14T11:20:56.093Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Qualcomm-Company-Office-In-Silicon-Valle.jpg?width=250&height=187 Qualcomm Bets Big on AI Smartphones With Dual Flagship Chips Qualcomm has introduced a dual-flagship chip strategy with the launch of the Snapdragon 8 Elite Gen 6 and Snapdragon 8 Elite Extreme Gen 6, aimed at enhancing premium smartphone offerings and supporting AI applications. This strategy is designed to provide smartphone manufacturers with flexibility in performance and design, catering to the growing demand for sustained processing power in AI, gaming, and content creation. Qualcomm's focus on thermal efficiency and advanced graphics capabilities is expected to improve user experiences, while positioning smartphones as central to the AI ecosystem across connected devices. During premarket trading, Qualcomm shares were down 0.44% at $176.08. https://www.openbell.ai/news/RAL:1791976788086 2026-10-14T11:19:48.086Z daily 0.9 https://cdn.brandfetch.io/RAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Seaport Global Upgrades Ralliant to Buy, Announces $88 Price Target Seaport Global analyst Scott Graham has upgraded Ralliant (NYSE: RAL) from a Neutral rating to a Buy rating. Along with the upgrade, a price target of $88 has been announced for the stock. https://www.openbell.ai/news/ZLAB:1791976330800 2026-10-14T11:12:10.800Z daily 0.9 https://cdn.brandfetch.io/ZLAB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zai Lab To Present First Phase 1/1b Data On Atopic Dermatitis Candidate ZL-1503 In Healthy Volunteers On November 13 openbell Financial News https://www.openbell.ai/news/RRC:1791976296646 2026-10-14T11:11:36.646Z daily 0.9 https://cdn.brandfetch.io/RRC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Range Resources Expects To Report Total Gain On Derivatives Of $58.1M For Three Months Ended September 30, 2026 Range Resources expects to report a total gain on derivatives of $58.1 million for the three months ended September 30, 2026, according to a recent SEC filing. This financial figure highlights the company's performance in managing its derivative contracts during the specified period. https://www.openbell.ai/news/DHR:1791976281857 2026-10-14T11:11:21.857Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/West-Bangal--India---April-20--2022--Dan.jpg?width=250&height=187 Danaher Brings NVIDIA AI Into Scientific Instruments in Push for Faster Discoveries Danaher Corporation (NYSE: DHR) announced a collaboration with NVIDIA Corp (NASDAQ: NVDA) to integrate AI into its scientific instruments, aiming to accelerate scientific discoveries. The partnership will leverage NVIDIA's AI technologies to enhance Danaher's laboratory software and automation, with initial efforts focusing on select instruments. Danaher is set to report third-quarter earnings on October 21, with analysts expecting EPS of $1.91 on revenue of $6.56 billion, reflecting growth from the previous year. In premarket trading, Danaher shares increased by 0.52% to $223.99. https://www.openbell.ai/news/BRN:1791976213110 2026-10-14T11:10:13.110Z daily 0.9 https://cdn.brandfetch.io/BRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barnwell Industries Posts Shareholder Q&A On Pending Sale Of Canadian Oil And Gas Business openbell Financial News https://www.openbell.ai/news/VKTX:1791976176357 2026-10-14T11:09:36.357Z daily 0.9 https://cdn.brandfetch.io/VKTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Viking Therapeutics Initiates SUNRISE Phase 3 Clinical Program For Oral VK2735 Dual Agonist Of GLP-1 And Glucose-Dependent Insulinotropic Polypeptide Receptors Viking Therapeutics has launched the SUNRISE Phase 3 clinical program for its oral VK2735, a dual agonist targeting GLP-1 and GIP receptors, aimed at treating metabolic disorders like obesity. The program consists of two randomized, double-blind, placebo-controlled studies, SUNRISE-1 and SUNRISE-2, each enrolling 560 adults over 68 weeks to assess the drug's efficacy and safety. The primary endpoint is the percent change in body weight from baseline, with various secondary endpoints evaluating additional weight reduction metrics. https://www.openbell.ai/news/ALP:1791976161463 2026-10-14T11:09:21.463Z daily 0.9 https://cdn.brandfetch.io/ALP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Alpha Compute Announces $81.7M Four-Year GPU Capacity Contract With Unnamed AI Compute Marketplace; Customer To Pay 25% In Advance openbell Financial News https://www.openbell.ai/news/CORZ:1791976087838 2026-10-14T11:08:07.838Z daily 0.9 https://cdn.brandfetch.io/CORZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target Cantor Fitzgerald analyst Brett Knoblauch has reiterated an Overweight rating on Core Scientific (NASDAQ: CORZ) while maintaining a price target of $39 for the stock. This indicates a positive outlook for the company's performance in the market. https://www.openbell.ai/news/TRDA:1791976083083 2026-10-14T11:08:03.083Z daily 0.9 https://cdn.brandfetch.io/TRDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Entrada Therapeutics Reports 0.10% Mean Dystrophin Increase In 5 mg/kg Cohort Of Phase 1/2 Duchenne Trial Of ENTR-601-45; Primary Safety Goal Met openbell Financial News https://www.openbell.ai/news/VBNK:1791976069231 2026-10-14T11:07:49.231Z daily 0.9 https://cdn.brandfetch.io/VBNK/w/400/h/400?c=1idopYfmtR7ZKg8QMud VersaBank Receives Approval From Canada's Finance Minister, François-Philippe Champagne, To Realign Its Corporate Structure To Standard US Bank Framework Reorganization VersaBank (TSX: VBNK, NASDAQ: VBNK) has received approval from Canada's Finance Minister, François-Philippe Champagne, to realign its corporate structure to a standard U.S. bank framework. This reorganization involves creating a new Delaware corporation, Versa Bancorp, which will serve as the direct holding company of the Bank. The reorganization is expected to be completed by the end of October 2026, pending approval from the Federal Reserve Board in the U.S., which remains uncertain. https://www.openbell.ai/news/TRDA:1791976069229 2026-10-14T11:07:49.229Z daily 0.9 https://cdn.brandfetch.io/TRDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Entrada Therapeutics Announces Independent Data Monitoring Committee Review Of All Available Safety And PK Data From The Eight Participants Enrolled In Cohort 2 Of The Double-Blind, Placebo-Controlled, Multiple Ascending Dose Portion of ELEVATE-44-201 Entrada Therapeutics announced that the Independent Data Monitoring Committee (DMC) has reviewed safety and pharmacokinetic data from eight participants in Cohort 2 of the ELEVATE-44-201 study. The DMC recommended advancing to Cohort 3 with a top dose of 18 mg/kg, up from 12 mg/kg in Cohort 2 and 6 mg/kg in Cohort 1. This Phase 1/2 clinical study is focused on the treatment of Duchenne muscular dystrophy (DMD) for participants with a specific mutation in the DMD gene. https://www.openbell.ai/news/ANGO:1791975960696 2026-10-14T11:06:00.696Z daily 0.9 https://cdn.brandfetch.io/ANGO/w/400/h/400?c=1idopYfmtR7ZKg8QMud AngioDynamics Says Humana Updates Medicare Advantage Policy To Cover NanoKnife For Eligible Prostate And Liver Cancer Patients, Effective October 1 openbell Financial News https://www.openbell.ai/news/PBLS:1791975929979 2026-10-14T11:05:29.979Z daily 0.9 https://cdn.brandfetch.io/PBLS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Parabilis Medicines Initiates Dose-Ranging Clinical Cohort Evaluating Zolucatetide In Patients With Familial Adenomatous Polyposis As Part Of Ongoing Phase 1/2 Clinical Trial Parabilis Medicines (NASDAQ: PBLS) has initiated a dose-ranging clinical cohort to evaluate zolucatetide in patients with familial adenomatous polyposis (FAP) as part of its ongoing Phase 1/2 clinical trial. Zolucatetide is the company's lead investigational peptide and is the first direct inhibitor of the β-catenin:TCF interaction, which is crucial in the development of various cancers. This new cohort builds on promising early clinical evidence observed in patients with FAP and desmoid tumors. https://www.openbell.ai/news/IVVD:1791975901499 2026-10-14T11:05:01.499Z daily 0.9 https://cdn.brandfetch.io/IVVD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Invivyd And SPEAR Study Group Initiate FLINTLOCK Phase 2 Trial Evaluating Safety, Tolerability, Pharmacokinetics, And Clinical Efficacy Of High-Dose Monoclonal Antibody VYD2311 In Individuals With Long COVID Or Post-Vaccination Syndrome Invivyd, in collaboration with the SPEAR Study Group, has initiated the Phase 2 FLINTLOCK clinical trial to evaluate the safety, tolerability, pharmacokinetics, and clinical efficacy of its monoclonal antibody VYD2311 for individuals suffering from Long COVID or Post-Vaccination Syndrome (PVS). The trial is a randomized, double-blind, placebo-controlled study that will administer a high-dose IV infusion of VYD2311, followed by monthly IM injections, targeting a total dose significantly higher than previous studies while remaining within a safe range. The trial aims to enroll adults aged 18-65 with confirmed Long COVID or PVS and will assess clinical efficacy and safety over a 90-day period, with initial data expected by mid-2027. https://www.openbell.ai/news/AYA:1791975872496 2026-10-14T11:04:32.496Z daily 0.9 https://cdn.brandfetch.io/AYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Aya Gold & Silver Reports Q3 Production of 2.03M AgEq Ounces, Up 51% YoY Aya Gold & Silver Inc. reported a record quarterly silver production of 2.03 million silver equivalent ounces (Moz AgEq) for Q3-2026, marking a 51% increase year-over-year and a 21% increase quarter-over-quarter. The Zgounder silver mine contributed 1.50 Moz Ag, up 11% YoY, while the Boumadine pyrite reclaim operation saw a significant 186% increase in production quarter-over-quarter. The company achieved a processing rate of 4,096 tonnes per day, reflecting a 5% increase from the previous quarter. https://www.openbell.ai/news/SOTK:1791975660934 2026-10-14T11:01:00.934Z daily 0.9 https://cdn.brandfetch.io/SOTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sono-Tek Q2 EPS $0.02 Misses $0.04 Estimate, Sales $5.232M Miss $5.538M Estimate openbell Financial News https://www.openbell.ai/news/JPM:1791975609947 2026-10-14T11:00:09.947Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Closeup-Of-Jamie-Dimon--Ceo-Of-Jpmorgan-.jpg?width=250&height=187 Jamie Dimon Warns Americans Could Pay the Price if the Fed Keeps Rates High for Too Long — ‘We Just Don’t Know When’ the Good Times Will End JPMorgan Chase & Co. CEO Jamie Dimon warned that prolonged high interest rates could negatively impact consumer credit, despite current consumer resilience and a 10% year-over-year increase in debit and credit card spending. The bank reported a net income of $15.3 billion, or $5.57 per share, on revenue of $50.91 billion, missing Wall Street expectations of $5.94 EPS on $51.26 billion revenue. Dimon emphasized the importance of caution in the face of potential economic challenges, including inflation and elevated asset prices, while the bank continues to support clients amid market volatility. https://www.openbell.ai/news/AQST:1791975503385 2026-10-14T10:58:23.385Z daily 0.9 https://cdn.brandfetch.io/AQST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Eton Pharmaceuticals And Aquestive Therapeutics Enter Exclusive U.S. License And Supply Agreement For LIBERVANT Buccal Film For Seizure Clusters In Patients With Epilepsy; Sees Commercial Availability In April 2027 Eton Pharmaceuticals and Aquestive Therapeutics have entered into an exclusive U.S. license and supply agreement for LIBERVANT, a buccal film for treating seizure clusters in epilepsy patients, with commercial availability expected in April 2027, pending FDA approval. The buccal film addresses a market opportunity exceeding $450 million annually in the U.S., with patient research indicating a strong preference for this form over nasal spray. LIBERVANT has received Orphan Drug Designation and is protected by patents extending to 2038, with additional applications pending. https://www.openbell.ai/news/SNDK:1791975453038 2026-10-14T10:57:33.038Z daily 0.9 https://cdn.brandfetch.io/SNDK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Sandisk Stock Falling Wednesday? Sandisk Corporation (NASDAQ: SNDK) saw its stock fall nearly 3% in premarket trading, dropping to $1,447.15, amid concerns regarding competition from China and the sustainability of AI-driven memory demand. The stock has declined below key short-term moving averages, indicating weakening momentum after a significant rally of approximately 1,064.53% over the past year. Investors are anticipating the upcoming earnings report scheduled for October 29, 2026, with consensus estimates predicting earnings of $46.22 per share on revenue of $10.64 billion. https://www.openbell.ai/news/SNDK:1791975443338 2026-10-14T10:57:23.338Z daily 0.9 https://cdn.brandfetch.io/SNDK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Is Sandisk Stock Falling Wednesday? Sandisk Corporation's stock (NASDAQ: SNDK) fell nearly 3% in premarket trading on Wednesday, continuing a decline attributed to concerns over competition from China and the sustainability of AI-driven memory demand. The stock is currently trading about 14.6% below its 20-day simple moving average and has gained approximately 1,064.53% over the past year, making it vulnerable to profit-taking. Investors are anticipating the next earnings report scheduled for October 29, 2026, with consensus estimates of $46.22 per share on revenue of $10.64 billion. https://www.openbell.ai/news/KSA:1791975383359 2026-10-14T10:56:23.359Z daily 0.9 https://cdn.brandfetch.io/KSA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Aramco's Dhahran HQ Suffered Extensive Damage In Tuesday's Attack, With Fire Spreading To Several Floors; Company Instructed Employees To Work From Home, Operations Are Continuing Normally; Moved Some Of Its Operations To Global Offices Aramco's headquarters in Dhahran experienced extensive damage due to an attack on Tuesday, resulting in fire spreading to several floors. In response, the company has instructed employees to work from home while continuing normal operations. Additionally, Aramco has relocated some of its operations to global offices. https://www.openbell.ai/news/ASML:1791975280245 2026-10-14T10:54:40.245Z daily 0.9 https://cdn.brandfetch.io/ASML/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'EU Set to Lift Sanction on Chinese Firm to Save ASML Supplier' - Bloomberg The European Union is preparing to lift sanctions on a Chinese firm to support ASML's supply chain. This decision aims to stabilize the supply of critical components for ASML, a leading supplier in the semiconductor industry. The move reflects the EU's strategic interest in maintaining competitiveness in the global market. https://www.openbell.ai/news/MSTR:1791975234307 2026-10-14T10:53:54.307Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/14/Bitcoin.jpg?width=250&height=187 Michael Saylor Expects Strategy to Crank Up Bitcoin Purchases as ‘Bull Market’ Takes Shape — Sees BTC Topping $100,000 This Cycle Michael Saylor, Executive Chair of Strategy Inc. (NASDAQ: MSTR), announced plans to increase Bitcoin (BTC) purchases as a bull market is anticipated, with expectations of BTC surpassing $100,000 this cycle. The company currently holds 848,250 BTC, valued at approximately $70.59 billion, making it the largest corporate holder of Bitcoin globally. Recently, Strategy acquired 250 BTC for $21.5 million, funded by selling shares and utilizing cash reserves. The firm's unrealized gains stand at nearly $7 billion. https://www.openbell.ai/news/ACN:1791975218891 2026-10-14T10:53:38.891Z daily 0.9 https://cdn.brandfetch.io/ACN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Accenture Targets Operating Margin Expansion Of 10-30bps Over FY27-29; Projects Mid-Single Digit Revenue Growth In FY27 And FY28, With Mid To High Single Digit Growth In FY29; Targets $5.5B Of Share Repurchases In FY27 Accenture has announced its targets for operating margin expansion, aiming for an increase of 10-30 basis points over the fiscal years 2027 to 2029. The company projects mid-single digit revenue growth for FY27 and FY28, with expectations of mid to high single digit growth in FY29. Additionally, Accenture plans to execute $5.5 billion in share repurchases in FY27. https://www.openbell.ai/news/FBK:1791975169047 2026-10-14T10:52:49.047Z daily 0.9 https://cdn.brandfetch.io/FBK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Reiterates Overweight on FB Financial, Maintains $65 Price Target Cantor Fitzgerald analyst Dave Rochester has reiterated an Overweight rating on FB Financial (NYSE: FBK) and maintained a price target of $65 for the stock. This indicates a positive outlook for the company's performance in the market.